105 related articles for article (PubMed ID: 20164547)
1. HLA-DR association in papillary thyroid carcinoma.
Amoli MM; Yazdani N; Amiri P; Sayahzadeh F; Haghpanah V; Tavangar SM; Amirzargar A; Ghaffari H; Nikbin B; Larijani B; Mostaan LV; Bazzaz JT
Dis Markers; 2010; 28(1):49-53. PubMed ID: 20164547
[TBL] [Abstract][Full Text] [Related]
2. Associations between HLA-C alleles and papillary thyroid carcinoma.
Haghpanah V; Khalooghi K; Adabi K; Amiri P; Tavangar SM; Amirzargar A; Ghaffari H; Yazdani N; Nikbin B; Larijani B; Amoli MM
Cancer Biomark; 2009; 5(1):19-22. PubMed ID: 19242058
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas.
Shuxian J; Xiaoyun C; Zhihui F; Xiaohua L; Zhanhui D; Bin H; Lin Z
Thyroid; 2014 May; 24(5):867-71. PubMed ID: 24308748
[TBL] [Abstract][Full Text] [Related]
5. Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances.
Juhasz F; Kozma L; Stenszky V; Gyory F; Luckas G; Farid NR
Cancer; 2005 Oct; 104(8):1603-8. PubMed ID: 16121403
[TBL] [Abstract][Full Text] [Related]
6. [HLA and thyroid cancer].
Dralle H; Robin-Winn M; Reilmann L; Laue A; Török M
Klin Wochenschr; 1986 Jun; 64(11):522-5. PubMed ID: 3459939
[TBL] [Abstract][Full Text] [Related]
7. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
8. HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study).
Kchir MM; Hamdi W; Laadhar L; Kochbati S; Kaffel D; Saadellaoui K; Lahmar H; Ghannouchi MM; Azzouz D; Daoud L; Ben Hamida A; Zouari B; Zitouni M; Makni S
Rheumatol Int; 2010 May; 30(7):933-9. PubMed ID: 19655145
[TBL] [Abstract][Full Text] [Related]
9. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.
Al-Jenaidi FA; Wakim-Ghorayeb SF; Al-Abbasi A; Arekat MR; Irani-Hakime N; Najm P; Al-Ola K; Motala AA; Almawi WY
J Clin Endocrinol Metab; 2005 Sep; 90(9):5104-9. PubMed ID: 15985473
[TBL] [Abstract][Full Text] [Related]
10. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
12. Susceptible and Protective Associations of HLA Alleles and Haplotypes with Cervical Cancer in South India.
Rathika C; Murali V; Dhivakar M; Kamaraj R; Malini RP; Ramgopal S; Balakrishnan K
Asian Pac J Cancer Prev; 2016; 17(5):2491-7. PubMed ID: 27268619
[TBL] [Abstract][Full Text] [Related]
13. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population.
Amirzargar A; Mytilineos J; Farjadian S; Doroudchi M; Scherer S; Opelz G; Ghaderi A
Hum Immunol; 2001 Nov; 62(11):1234-8. PubMed ID: 11704285
[TBL] [Abstract][Full Text] [Related]
15. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
[TBL] [Abstract][Full Text] [Related]
16. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
17. Susceptible and protective HLA-DR and HLA-DQ alleles for Fy
Raos M; Zunec R; Mocibob M; Gojceta K; Lukic M; Golubic Cepulic B
Transfusion; 2019 Mar; 59(3):1118-1124. PubMed ID: 30548476
[TBL] [Abstract][Full Text] [Related]
18. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
19. HLA class II allele and haplotype frequencies in iranian patients with acute myelogenous leukemia and control group.
Sarafnejad A; Khosravi F; Alimoghadam K; Dianat S; Ansaripour B; Moradi B; Dorkhosh S; Amirzargar A
Iran J Allergy Asthma Immunol; 2006 Sep; 5(3):115-9. PubMed ID: 17237562
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune type 1 diabetes genetic susceptibility encoded by human leukocyte antigen DRB1 and DQB1 genes in Tunisia.
Stayoussef M; Benmansour J; Al-Irhayim AQ; Said HB; Rayana CB; Mahjoub T; Almawi WY
Clin Vaccine Immunol; 2009 Aug; 16(8):1146-50. PubMed ID: 19553558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
